Three-Drug immune cocktail takes on pancreatic cancer
Disease control
Terminated
This study tests whether combining three immunotherapy drugs (domvanalimab, zimberelimab, and APX005M) can safely control metastatic pancreatic cancer. The trial enrolls 46 people whose cancer has spread and standard treatments have stopped working. Researchers will monitor side …
Phase: PHASE1, PHASE2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC